Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Ichitan Group
Watchlist
ICHI: Terpene Products to Be the Key Highlight in 2Q21
Equity Bottom-Up
278 Views
20 Apr 2021 03:00
Broker
We reiterate our BUY rating with a target price at Bt16.50, derived from 26.6xPE’21E which is equal to Asia-ex Japan consumer staple peer, slightly higher than ICHI’s 5-years average at 25.2xPE.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
ICHI : Solid Growth in Tansansu Sales Should Boost 4Q22 Earnings
ICHI : Healthy Outlook in 2H22
ICHI: Disappointing 1Q22 Result Already in the Price
ICHI: Strong Earnings Momentum with Attractive Dividend Yield
ICHI: Bright Outlook in 2022 and Beyond
Trending Collections
More »
India
Equity Bottom-Up
Index Rebalance
Japan
Event-Driven
Sell / Short Ideas
Philippines
Asia Event-Driven
China
Macroeconomics
Trending Insights
More »
7&I (3382 JP) - Alimentation Couche-Tard Walks, Lobbing a Letter Bomb
[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender - Surprising Results and Implications
UK Jobs Data And The Muddled MPC
Supreme Court's Final Ruling on Samsung's Lee Jae-Yong on 17 July: Impact on Samsung Group Companies
TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue
Top Unpaywalled Insights
More »
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
ICHI: Disappointing 1Q22 Result Already in the Price
13 May 2022
ICHI: Strong Earnings Momentum with Attractive Dividend Yield
10 Mar 2022
ICHI: Bright Outlook in 2022 and Beyond
03 Mar 2022
ICHI: Terpene Products to Be the Key Highlight in 2Q21
20 Apr 2021
ICHI: First Mover in Hemp-Related Products
04 Mar 2021
ICHI: Healthy Earnings in 4Q20E and Fresh Outlook in 1H21
26 Jan 2021
ICHI: Fresh Outlook in 2021 Thanks to Functional Drinks
19 Nov 2020
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x